Givinostat is a small molecule histone deacetylase (HDAC) inhibitor. It has been investigated as a treatment for a variety of inflammatory diseases, like Crohn’s disease and juvenile idiopathic arthritis, cancers like leukemia and lymphoma, as well as several muscular dystrophies. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester and Duvyzat. Its PubChem CID is 9804992.
Givinostat
| CAS No | 497833-27-9 |
|---|---|
| Molecular Formula | C24H27N3O4 |
| Molecular Weight | 421.5 g/mol |
| Synonyms | [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Givinostat is a small molecule histone deacetylase (HDAC) inhibitor. It has been investigated as a treatment for a variety of inflammatory diseases, like Crohn's disease and juvenile idiopathic arthritis, cancers like leukemia and lymphoma, as well as several muscular dystrophies.
The listed CAS number is 497833-27-9.
The listed molecular formula is C24H27N3O4.
The listed molecular weight is 421.5 g/mol.
[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate.
The source lists Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester and Duvyzat.